New
ScienceMore in Science→
Testosterone use for menopause rises despite limited evidence
Key Takeaways
- More than 90,000 off-label testosterone prescriptions were recorded for U.S. women in 2025.
- The total was 58.7% higher than in 2024.
- The FDA has not approved testosterone to treat menopause, and evidence for symptom relief is limited.
DE
DT Editorial Team··via livescience.com